Article info

Download PDFPDF
The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events
  1. Dr J P Leombruno, Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College Street, Suite 604, Toronto, Ontario, Canada M5S 3M2; john.leombruno{at}utoronto.ca
View Full Text

Citation

Leombruno JP, Einarson TR, Keystone EC
The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events

Publication history

  • Accepted August 3, 2008
  • First published August 27, 2008.
Online issue publication 
March 09, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.